Intrepid today announced that it served as the exclusive financial advisor to Southwestern Eye Center, Ltd. (SW Eye) on receiving a strategic investment from H.I.G. Capital (H.I.G.). Founded in 1982, SW Eye is a premier provider of comprehensive optometry and ophthalmology services across the Southwest. For more than 30 years, SW Eye has been a leader in providing best-in-class surgical and clinical ophthalmic care to patients in the Phoenix metro area and throughout Arizona and New Mexico, including a strong commitment to providing care in underserved rural areas.
“We are incredibly excited to begin our partnership with H.I.G. Capital and continue to build a leader in optometry and ophthalmology that is well-positioned for long-term growth,” said Dr. Lothaire Bluth, Founder and Chairman of SW Eye. “Intrepid helped us negotiate a transaction that will position SW Eye to provide a breadth and quality of eye care services unmatched in the country.”
“Dr. Bluth is a visionary leader who pioneered the concept of bringing comprehensive eye care to rural and underserved areas. The investment by H.I.G. will allow SW Eye to navigate the changes in the healthcare landscape and deliver best-in-class services for patients with both optometric and surgical needs across the Southwestern U.S.,” commented Jonathan Bluth, Senior Vice President and Head of Healthcare at Intrepid.
Dr. Bluth will serve as Chairman of the Board, and the company will continue to provide comprehensive optometry and ophthalmology services, including subspecialty procedures in vitreoretinal disease, oculoplastics, cornea disease, glaucoma, refractive procedures, low vision aids and ocular prosthetics throughout Arizona and New Mexico.
Deal Team Contact
About Intrepid’s Healthcare Group
Intrepid’s Healthcare Group is dedicated to providing strategic advice in capital raises and mergers and acquisitions across a broad range of healthcare sectors, including behavioral health, devices, hospitals, IT, pharmacy, physician practice management, post-acute care, and revenue cycle management. Our team maintains extensive relationships with strategic buyers and institutional investors across these sectors.